SciTech Daily
Survival of Critically Ill Covid-19 Patients Doubled by Birth Cord Stem Cell Treatment
Alphamed Press
June 8, 2021
Critically ill COVID-19 patients treated with non-altered stem cells from umbilical cord connective tissue were more than twice as likely to survive as those who did not have the treatment, according to a study published today (June 8, 2021) in STEM CELLS Translational Medicine.
The clinical trial, carried out at four hospitals in Jakarta, Indonesia, also showed that administering the treatment to COVID-19 patients with an added chronic health condition such as diabetes, hypertension or kidney disease increased their survival more than fourfold.